Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies. (Q33361984)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies. |
scientific article |
Statements
Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies (English)
Tadeusz Robak
Piotr Smolewski
Marek Kasznicki
Jerzy Z Blonski
Halina Urbanska-Rys
1 reference
1 reference
1 reference
1 reference